Skip to search formSkip to main contentSkip to account menu

L-S 519

Known as: LS 519, LS-519, LS519 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PirenzepinePirenzepine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Postprandial pancreatic exocrine secretion in dogs after oral administration of pirenzepine dihydrochloride.
The effect of orally administered 1,5-dihydroxy-11-(4-methyl-1-piperazinyl)- acetyl-6H-pyrido[2,3-b]-1,4-benzodiazepin-6-one… 
1984
1984
Pirenzepine (LS519) 注射剤の臨床第1相試験
1982
1982
Pirenzepine (LS 519): a weak inhibitor of acid secretion by isolated rat parietal cells.
1981
1981
Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
Absorption, distribution and excretion of 14C-labelled 5,11-dihydro-11-[(4-methyl-1-piperazinyl) acetyl]-6H-pyrido[2,3-b][1,4… 
1980
1980
ヒトにおけるPirenzepine-dihydrochloride (LS-519) の血漿中濃度および尿中排泄率
1978
1978
[Several new inhibitors of gastric secretion].
In experiments on dogs, milid (proglymid) entailed a weak inhibition of the 2nd phase of the gastric secretion leaving intact the… 
1975
1975
Proceedings: The effect of LS 519 CL2 on the level and uptake of serotonin by thrombocytes.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)